Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Shuttle Pharmaceuticals Holdings Inc SHPH

Healthcare Biotechnology
Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company. The Company is focused on improving the outcomes of cancer patients treated with radiation therapy (RT). It is developing a pipeline of products designed to address cancer therapies as well as to extend to the new applications of radiation therapy. Its product candidates include... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SHPH)

Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswire 10 days ago

Shuttle Pharma Pays Off Senior Secured Convertible Note

GlobeNewswire 10 days ago

Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

GlobeNewswire 11 days ago

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

GlobeNewswire 11 days ago

Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024

GlobeNewswire 12 days ago

Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

GlobeNewswire September 16, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Accesswire September 11, 2024

Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease

GlobeNewswire September 5, 2024

Shuttle Pharma Provides Second Quarter 2024 Corporate Update

GlobeNewswire September 4, 2024
View More News ››

Opinion & Analysis (NDAQ:SHPH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SHPH)

SHPH Offering and Pays of Senior Debt

GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the...
AveragePenny - 10 days ago

Shuttle Pharma Doses First Patients in Phase 2 Clinical ...

GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a...
AveragePenny - 11 days ago

SHPH QUANTUM LEAP NEXT GENERATION CANCER RADIATION TREATMENT

Shuttle Pharmaceuticals’ Ropidoxuridine Could Substantially Increase Demand for Improved and Cost-Effective Cancer Radiation Treatments...
AveragePenny - October 25, 2024

SHPH..... $1.75 now

Done  I rest my case
Iseneschal - September 6, 2024

SHPH...... This a.m low was $1.85

I'll say it now .... You've all been had ...... AGAIN !!!!!
Iseneschal - September 6, 2024

SHPH....N.L.O.D $2.165

The worst is yet to come.....wait for it Sub $2 anyone???
Iseneschal - September 5, 2024
View more Bullboard ››

NexTech3D.AI Corp.

NexTech3D.AI Corp.

NexTech3D.AI Corp. is a diversified augmented reality (AR), artificial intelligence (AI) technology company. The Company ...
View More »